Clinical Trial Update: Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function. [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics and safety of apraglutide in participants with normal and impaired kidney function (Chronic Kidney Disease); result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Apraglutide (apraglutide)

Snippet

Sponsor: VectivBio AG | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-05-15